These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement. Criscuolo E; Giuliani B; Castelli M; Cavallaro M; Sisti S; Burioni R; Ferrari D; Mancini N; Locatelli M; Clementi N Front Immunol; 2024; 15():1501200. PubMed ID: 39664381 [TBL] [Abstract][Full Text] [Related]
29. Performance of rapid antigen tests to detect SARS-CoV-2 variant diversity and correlation with viral culture positivity: implication for diagnostic development and future public health strategies. Goux H; Green J; Wilson A; Sozhamannan S; Richard SA; Colombo R; Lindholm DA; Jones MU; Agan BK; Larson D; Saunders DL; Mody R; Cox J; Deans R; Walish J; Fries A; Simons MP; Pollett SD; Smith DR mBio; 2024 Dec; 15(12):e0273724. PubMed ID: 39480114 [TBL] [Abstract][Full Text] [Related]
30. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen. MacLean OA; Lytras S; Weaver S; Singer JB; Boni MF; Lemey P; Kosakovsky Pond SL; Robertson DL PLoS Biol; 2021 Mar; 19(3):e3001115. PubMed ID: 33711012 [TBL] [Abstract][Full Text] [Related]
31. Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Canada: Longitudinal Trend Analysis. Wu SA; Soetikno AG; Ozer EA; Welch SB; Liu Y; Havey RJ; Murphy RL; Hawkins C; Mason M; Post LA; Achenbach CJ; Lundberg AL JMIR Public Health Surveill; 2024 Dec; 10():e53218. PubMed ID: 39471286 [TBL] [Abstract][Full Text] [Related]
32. Human placental cells are resistant to SARS-CoV-2 infection and replication. Yoshida N; Thomas JR; Appios A; Brember MP; Aye ILMH; Edgar JR; Firth AE; Chung BYW; McGovern N; Stewart H Wellcome Open Res; 2024; 9():209. PubMed ID: 39640372 [TBL] [Abstract][Full Text] [Related]
33. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination. Bugalia S; Tripathi JP; Wang H J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066 [TBL] [Abstract][Full Text] [Related]
34. The effects of Remdesivir's functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymerase. Sama B; Selisko B; Falcou C; Fattorini V; Piorkowski G; Touret F; Donckers K; Neyts J; Jochmans D; Shannon A; Coutard B; Canard B Antiviral Res; 2024 Dec; 232():106034. PubMed ID: 39510431 [TBL] [Abstract][Full Text] [Related]
35. An analytical, numerical and experimental study of in-vitro SARS-CoV-2 evolution in Vero B4 cells. Nicol M; Sng JDJ; Zhu Y; Sonnleitner ST; Short KR; Carney M J Theor Biol; 2025 Feb; 598():112000. PubMed ID: 39586460 [TBL] [Abstract][Full Text] [Related]
36. Defining within-host SARS-CoV-2 RNA viral load kinetics during acute COVID-19 infection within different respiratory compartments and their respective associations with host infectiousness: a protocol for a systematic review and meta-analysis. Pan D; Martin CA; Nazareth J; Sze S; Al-Oraibi A; Gogoi M; Grolmusova N; Divall P; Decker J; Fletcher E; Williams C; Hay J; Baggaley RF; Wyllie AL; Stephenson I; Gaillard E; Nellums LB; Clark TW; Van-Tam JN; Cowling BJ; Hollingsworth TD; Gray L; Barer M; Pareek M BMJ Open; 2024 Dec; 14(12):e085127. PubMed ID: 39622563 [TBL] [Abstract][Full Text] [Related]
37. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant. Khan K; Lustig G; Römer C; Reedoy K; Jule Z; Karim F; Ganga Y; Bernstein M; Baig Z; Jackson L; Mahlangu B; Mnguni A; Nzimande A; Stock N; Kekana D; Ntozini B; van Deventer C; Marshall T; Manickchund N; Gosnell BI; Lessells RJ; Karim QA; Abdool Karim SS; Moosa MS; de Oliveira T; von Gottberg A; Wolter N; Neher RA; Sigal A Nat Commun; 2023 Dec; 14(1):8078. PubMed ID: 38057313 [TBL] [Abstract][Full Text] [Related]
38. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Tang J; Zeng C; Cox TM; Li C; Son YM; Cheon IS; Wu Y; Behl S; Taylor JJ; Chakaraborty R; Johnson AJ; Shiavo DN; Utz JP; Reisenauer JS; Midthun DE; Mullon JJ; Edell ES; Alameh MG; Borish L; Teague WG; Kaplan MH; Weissman D; Kern R; Hu H; Vassallo R; Liu SL; Sun J Sci Immunol; 2022 Oct; 7(76):eadd4853. PubMed ID: 35857583 [TBL] [Abstract][Full Text] [Related]
39. A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. Rihn SJ; Merits A; Bakshi S; Turnbull ML; Wickenhagen A; Alexander AJT; Baillie C; Brennan B; Brown F; Brunker K; Bryden SR; Burness KA; Carmichael S; Cole SJ; Cowton VM; Davies P; Davis C; De Lorenzo G; Donald CL; Dorward M; Dunlop JI; Elliott M; Fares M; da Silva Filipe A; Freitas JR; Furnon W; Gestuveo RJ; Geyer A; Giesel D; Goldfarb DM; Goodman N; Gunson R; Hastie CJ; Herder V; Hughes J; Johnson C; Johnson N; Kohl A; Kerr K; Leech H; Lello LS; Li K; Lieber G; Liu X; Lingala R; Loney C; Mair D; McElwee MJ; McFarlane S; Nichols J; Nomikou K; Orr A; Orton RJ; Palmarini M; Parr YA; Pinto RM; Raggett S; Reid E; Robertson DL; Royle J; Cameron-Ruiz N; Shepherd JG; Smollett K; Stewart DG; Stewart M; Sugrue E; Szemiel AM; Taggart A; Thomson EC; Tong L; Torrie LS; Toth R; Varjak M; Wang S; Wilkinson SG; Wyatt PG; Zusinaite E; Alessi DR; Patel AH; Zaid A; Wilson SJ; Mahalingam S PLoS Biol; 2021 Feb; 19(2):e3001091. PubMed ID: 33630831 [TBL] [Abstract][Full Text] [Related]